GUBRA.CO
Gubra A/S
Price history
Key metrics
Gubra A/S has paid a dividend for 1 consecutive year and currently yields 20.22%, above its five year average. Its payout ratio is 60%. Dividend Health rates it Borderline at 52 out of 99, with medium confidence.
Data as of 26 Sept 2026
Dividend health
Confidence Medium · Defensive profile · as of 26 Sept 2026
Total return
DKK 10,000 invested is DKK 31,131 today: DKK 17,509 from the share price and DKK 3,622 from dividends reinvested.
Total return +211.31%. Price alone returned +175.09% over the same window.
Assumes every dividend is reinvested on its ex-dividend date, before tax and dealing costs.
How it compares
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry; and various services in vivo pharmacology, biomarker assays, bioinformatics, next gen sequencing, bioinformatics, and 2D and 3D histology with artificial intelligence pathology. It also has a portfolio strategy of potential drug candidates in the form of upfront payments, research payments, milestone payments, and royalties; and investments targeting as sets promoting the green transition. The company has partnership and collaboration with Boehringer Ingelheim for the treatment of obesity; Camurus' FluidCrystal technology to develop a therapy for hypoparathyroidism; Amylyx Pharmaceuticals to develop a GLP-1 receptor antagonist for post-bariatric hypoglycemia and other rare diseases. Gubra A/S was incorporated in 2008 and is headquartered in Horsholm, Denmark.
Annual dividends per share
Dividends paid in DKK · based on GUBRA.CO's fiscal years ending in December
Dividend Policy
Gubra intends to apply all available financial resources for the purposes of current and future business development. The company currently intends to retain all available financial resources and any earnings generated by its operations for use of implementing its strategy and does not anticipate paying any dividends until such strategy is implemented.
Dividend History
| Ex-Date | Amount | Status |
|---|---|---|
| 30 Jun 252025-06-30 | DKK 61.2000 | Paid |
This page is for informational purposes only and does not constitute investment advice. Past dividend payments are not a guarantee of future payments. All data is sourced from public market data and may be delayed. Always do your own research before making any investment decisions.
Your dividend income, mapped.
Free for up to 25 holdings. No credit card. Import your first portfolio in under a minute.
Get started free